{
    "clinical_study": {
        "@rank": "60384", 
        "arm_group": [
            {
                "arm_group_label": "oral paracetamol", 
                "arm_group_type": "Active Comparator", 
                "description": "patients in this arm will receive 1000mg of oral paracetamol"
            }, 
            {
                "arm_group_label": "Intravenous paracetamol", 
                "arm_group_type": "Active Comparator", 
                "description": "patients in this arm will receive 1000 mg of intravenous paracetamol"
            }, 
            {
                "arm_group_label": "Intramuscular Diclofenac", 
                "arm_group_type": "Active Comparator", 
                "description": "patients in this arm will receive 75 mg of intramuscular diclofenac sodium"
            }
        ], 
        "brief_summary": {
            "textblock": "A randomized clinical trial to check the antipyretic efficacy of oral and intravenous\n      paracetamol and intramuscular diclofenac sodium in patients presenting with fever to\n      emergency department."
        }, 
        "brief_title": "The Antipyretic Efficacy of Oral and Intravenous Paracetamol and Intramuscular Diclofenac in Patients Presenting With Fever.", 
        "completion_date": {
            "#text": "April 2013", 
            "@type": "Actual"
        }, 
        "condition": [
            "Fever", 
            "Reduction in Temperature"
        ], 
        "condition_browse": {
            "mesh_term": "Fever"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Adults between the age of 14-75 years with an oral temperature of more than 38.5 C\n\n        Exclusion Criteria:\n\n          -  History of allergy to any of the drugs in the study\n\n          -  Had taken antipyretics within 8 hours\n\n          -  Renal, hepatic or haematological disorders\n\n          -  bronchial asthma, peptic ulcer disease, vomiting\n\n          -  Pregnant or lactating women"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "75 Years", 
            "minimum_age": "14 Years"
        }, 
        "enrollment": {
            "#text": "434", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "June 21, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01891435", 
            "org_study_id": "9070/09"
        }, 
        "intervention": [
            {
                "arm_group_label": "oral paracetamol", 
                "description": "after giving medicine temperature is checked every 30 minutes for 2 hours", 
                "intervention_name": "Oral paracetamol", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "Intravenous paracetamol", 
                "description": "after giving medicine temperature is checked every 30 minutes for 2 hours", 
                "intervention_name": "Intravenous paracetamol", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "Intramuscular Diclofenac", 
                "description": "after giving medicine temperature is checked every 30 minutes for 2 hours", 
                "intervention_name": "Intramuscular diclofenac", 
                "intervention_type": "Drug"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Acetaminophen", 
                "Antipyretics", 
                "Diclofenac"
            ]
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "keyword": [
            "antipyretics", 
            "oral paracetamol", 
            "intravenous paracetamol", 
            "intramuscular diclofenac", 
            "emergency department"
        ], 
        "lastchanged_date": "June 28, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "Doha", 
                    "country": "Qatar", 
                    "zip": "3050"
                }, 
                "name": "Hamad medical corporation"
            }
        }, 
        "location_countries": {
            "country": "Qatar"
        }, 
        "number_of_arms": "3", 
        "official_title": "A Randomized Controlled Clinical Trial on the Antipyretic Efficacy of Oral Paracetamol, Intravenous Paracetamol and Intramuscular Diclofenac in Patients Presenting With Fever to Emergency Department", 
        "overall_official": {
            "affiliation": "Hamad Medical Corporation", 
            "last_name": "osama H Mohammed", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "Qatar: Hamad Medical Corporation"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "December 2011", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "description": "Once the patients fulfill the inclusion criteria, they are randomly assigned to receive one of the three medications in the study ( oral paracetamol,  intravenous paracetamol or intramuscular diclofenac). Baseline temperature is recorded using a standard thermometer. Then reduction in temperature is recorded every 30 minutes for 2 hours.", 
            "measure": "Reduction in temperature in every thirty minutes till 120 minutes after receiving antipyretics", 
            "safety_issue": "Yes", 
            "time_frame": "Reduction in temperature is checked every 30 minutes for a maximum of 120 minutes"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01891435"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Hamad Medical Corporation", 
            "investigator_full_name": "Firjeeth C Paramba", 
            "investigator_title": "Specialist, Emergency Department", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "source": "Hamad Medical Corporation", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Hamad Medical Corporation", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "January 2010", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "June 2013"
    }
}